trending Market Intelligence /marketintelligence/en/news-insights/trending/tu0vp7nqbt-m_tnmi80tvq2 content esgSubNav
In This List

Astellas names chief medical officer

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Astellas names chief medical officer

Astellas Pharma Inc. promoted Bernhardt Zeiher to the position of chief medical officer, effective April 1.

Zeiher will continue serving as president of development while also overseeing all other functions of Astellas' medical and development organization, including clinical and research quality assurance, medical affairs, pharmacovigilance, planning and administration and regulatory affairs.

Zeiher, who began his career at Astellas in 2010 as vice president and therapeutic area leader, was previously promoted to president of development in 2015.

Tokyo-based Astellas Pharma is a pharmaceutical company, which manufactures, markets, and imports/exports pharmaceutical products worldwide.